Lv3
318 积分 2023-07-05 加入
Precision treatment guided by patient-derived organoids-based drug testing for locally advanced thyroid cancer: a single arm, phase 2 study
12小时前
待确认
Progression-Free Survival: Meaningful or Simply Measurable?
1个月前
已关闭
EGFR activation limits the response of liver cancer to lenvatinib
1个月前
已完结
Risk of Variceal Bleeding in Patients With Advanced Hepatocellular Carcinoma Receiving Atezolizumab/Bevacizumab
2个月前
已完结
Management of portal hypertension in patients treated with atezolizumab and bevacizumab for hepatocellular carcinoma
2个月前
已关闭
Clinical outcomes of hepatic arterial infusion chemotherapy combined with tyrosine kinase inhibitors and anti‐PD‐1 immunotherapy for unresectable intrahepatic cholangiocarcinoma
2个月前
已完结
Clinical and biomarker analyses of hepatic arterial infusion chemotherapy plus lenvatinib and PD-1 inhibitor for patients with advanced intrahepatic cholangiocarcinoma
2个月前
已完结
Effect of different PD‐1 inhibitor combination therapies for unresectable intrahepatic cholangiocarcinoma
2个月前
已完结
Preoperative Immunotherapy in Hepatocellular Carcinoma: Current State of the Art
10个月前
已完结
Neoadjuvant Immunotherapy for Hepatocellular Carcinoma
10个月前
已完结
皖公网安备34019202002308
